{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,10]],"date-time":"2026-08-10T07:31:31Z","timestamp":1786347091716,"version":"build-2736575974"},"reference-count":30,"publisher":"Wiley","issue":"1","license":[{"start":{"date-parts":[[2026,8,10]],"date-time":"2026-08-10T00:00:00Z","timestamp":1786320000000},"content-version":"vor","delay-in-days":221,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"},{"start":{"date-parts":[[2026,1,1]],"date-time":"2026-01-01T00:00:00Z","timestamp":1767225600000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/doi.wiley.com\/10.1002\/tdm_license_1.1"}],"content-domain":{"domain":["onlinelibrary.wiley.com"],"crossmark-restriction":true},"short-container-title":["Canadian Journal of Gastroenterology and Hepatology"],"published-print":{"date-parts":[[2026,1]]},"abstract":"<jats:sec>\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>PD\u20101 blockade has yet to achieve broad clinical success in colorectal cancer (CRC), with microsatellite\u2010stable tumors proving especially resistant. At the same time, ferroptosis has emerged as a mechanistic link between redox control in tumor cells and the antitumor immune response. GPR39 is overexpressed in CRC, but its functional role in ferroptosis and immunotherapy resistance is currently unclear.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>\n                      GPR39 expression was analyzed in human and mouse CRC cell lines. GPR39 knockdown, with or without the ferroptosis inhibitor liproxstatin\u20101, was performed to determine whether GPR39 regulates CRC cell proliferation and migration through ferroptosis. Ferroptosis was evaluated by measuring lipid peroxidation, glutathione (GSH) levels, ferrous iron (Fe\n                      <jats:sup>2+<\/jats:sup>\n                      ) accumulation, and reactive oxygen species (ROS). Mechanistic involvement of the nuclear factor erythroid 2\u2013related factor 2 (Nrf2)\/solute carrier family 7 member 11 (SLC7A11) signaling axis was examined using Nrf2 overexpression. Subcutaneous implantation of MC38 cells with stable GPR39 knockdown was performed to evaluate whether GPR39 regulates tumor sensitivity to anti\u2010PD\u20101 treatment in vivo in a ferroptosis\u2010dependent manner.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>\n                      GPR39 was markedly upregulated in CRC cell lines. GPR39 knockdown induced ferroptosis, characterized by increased lipid peroxidation, Fe\n                      <jats:sup>2+<\/jats:sup>\n                      accumulation, and oxidative stress and accompanied by suppression of the Nrf2\/SLC7A11 pathway. Nrf2 overexpression reversed these changes. Functionally, silencing GPR39 inhibited the proliferative and migratory capacities of CRC cells, effects that were largely rescued by liproxstatin\u20101. In vivo, GPR39 knockdown significantly potentiated the antitumor activity of PD\u20101 blockade, as evidenced by suppressed tumor progression accompanied by enhanced infiltration of CD8\n                      <jats:sup>+<\/jats:sup>\n                      T cells, whereas ferroptosis inhibition abrogated these effects.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusion<\/jats:title>\n                    <jats:p>GPR39 suppresses ferroptosis in CRC via the Nrf2\/SLC7A11 axis, thereby limiting PD\u20101 immunotherapy efficacy.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1155\/cjgh\/5689742","type":"journal-article","created":{"date-parts":[[2026,8,10]],"date-time":"2026-08-10T07:25:29Z","timestamp":1786346729000},"update-policy":"https:\/\/doi.org\/10.1002\/crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["GPR39 Suppresses Ferroptosis via the Nrf2\/SLC7A11 Axis and Reduces the Sensitivity of Colorectal Cancer to Anti\u2010PD\u20101 Immunotherapy"],"prefix":"10.1155","volume":"2026","author":[{"given":"Cong","family":"Zhou","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaoling","family":"Fang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jiaying","family":"Lin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiang","family":"Jiang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Huihui","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0007-6618-4753","authenticated-orcid":false,"given":"Jiaoe","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0005-7017-9805","authenticated-orcid":false,"given":"Qiang","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"311","published-online":{"date-parts":[[2026,8,10]]},"reference":[{"key":"e_1_2_15_1_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.bpg.2023.101839"},{"key":"e_1_2_15_2_2","doi-asserted-by":"publisher","DOI":"10.1272\/jnms.jnms.2022_89-310"},{"key":"e_1_2_15_3_2","doi-asserted-by":"publisher","DOI":"10.1038\/s41392-023-01522-4"},{"key":"e_1_2_15_4_2","doi-asserted-by":"publisher","DOI":"10.1111\/imm.13785"},{"key":"e_1_2_15_5_2","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2022.1016646"},{"key":"e_1_2_15_6_2","doi-asserted-by":"publisher","DOI":"10.1111\/febs.16034"},{"key":"e_1_2_15_7_2","article-title":"Mefloquine Enhances the Efficacy of Anti-PD-1 Immunotherapy via IFN-\u03b3-STAT1-IRF1-LPCAT3-Induced Ferroptosis in Tumors","volume":"12","author":"Qian T.","year":"2024","journal-title":"Journal for Immunotherapy of Cancer"},{"key":"e_1_2_15_8_2","article-title":"Abrogation of HnRNP L Enhances Anti-PD-1 Therapy Efficacy via Diminishing PD-L1 and Promoting CD8(+) T Cell-Mediated Ferroptosis in Castration-Resistant Prostate Cancer","volume":"12","author":"Xumin Z.","year":"2022","journal-title":"Acta Pharmaceutica Sinica B"},{"key":"e_1_2_15_9_2","article-title":"Simvastatin Induces Ferroptosis and Activates Anti-Tumor Immunity to Sensitize Anti-PD-1 Immunotherapy in Microsatellite Stable Gastric Cancer","volume":"142","author":"Yumei N.","year":"2024","journal-title":"International Immunopharmacology"},{"key":"e_1_2_15_10_2","article-title":"Icariin Promoted Ferroptosis by Activating Mitochondrial Dysfunction to Inhibit Colorectal Cancer and Synergistically Enhanced the Efficacy of PD-1 Inhibitors","volume":"136","author":"Wang H.","year":"2024","journal-title":"Phytomedicine"},{"key":"e_1_2_15_11_2","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2023.1255443"},{"key":"e_1_2_15_12_2","doi-asserted-by":"publisher","DOI":"10.1146\/annurev-immunol-101819-024752"},{"key":"e_1_2_15_13_2","doi-asserted-by":"publisher","DOI":"10.3390\/ijms232012133"},{"key":"e_1_2_15_14_2","article-title":"Overexpression of GPR39 Contributes to Malignant Development of Human Esophageal Squamous Cell Carcinoma","volume":"11","author":"Fajun X.","year":"2011","journal-title":"BMC Cancer"},{"key":"e_1_2_15_15_2","article-title":"The Expression and Clinical Significance of GPR39 in Colon Cancer","volume":"191","author":"Xiaoqian W.","year":"2021","journal-title":"Irish Journal of Medical Science"},{"key":"e_1_2_15_16_2","doi-asserted-by":"publisher","DOI":"10.1038\/cddis.2014.262"},{"key":"e_1_2_15_17_2","doi-asserted-by":"publisher","DOI":"10.1098\/rstb.2015.0420"},{"key":"e_1_2_15_18_2","doi-asserted-by":"publisher","DOI":"10.3390\/antiox12091739"},{"key":"e_1_2_15_19_2","article-title":"ARD1 Stabilizes NRF2 Through Direct Interaction and Promotes Colon Cancer Progression","volume":"313","author":"Xizhu F.","year":"2022","journal-title":"Life Sciences"},{"key":"e_1_2_15_20_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.ccell.2024.10.010"},{"key":"e_1_2_15_21_2","article-title":"The Mechanism Underlying the TC-G 1008 Rescue of Reactive Oxygen Species (ROS)-Induced Osteoblast Apoptosis by the Upregulation of Peroxiredoxin 1","volume":"151","author":"Panpan Y.","year":"2022","journal-title":"The International Journal of Biochemistry & Cell Biology"},{"key":"e_1_2_15_22_2","article-title":"G Protein-Coupled Receptor 39 Alleviates Mitochondrial Dysfunction and Hepatocyte Lipid Accumulation via SIRT1\/Nrf2 Signaling","volume":"55","author":"Qiang C.","year":"2022","journal-title":"Journal of Bioenergetics and Biomembranes"},{"key":"e_1_2_15_23_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.gene.2025.149625"},{"key":"e_1_2_15_24_2","doi-asserted-by":"publisher","DOI":"10.3390\/ijms22083872"},{"key":"e_1_2_15_25_2","doi-asserted-by":"publisher","DOI":"10.1186\/s12967-021-03042-7"},{"key":"e_1_2_15_26_2","doi-asserted-by":"publisher","DOI":"10.1158\/0008-5472.can-24-2745"},{"key":"e_1_2_15_27_2","doi-asserted-by":"publisher","DOI":"10.3390\/antiox11122444"},{"key":"e_1_2_15_28_2","doi-asserted-by":"publisher","DOI":"10.1038\/s41418-018-0246-9"},{"key":"e_1_2_15_29_2","doi-asserted-by":"publisher","DOI":"10.1007\/s10495-024-01988-9"},{"key":"e_1_2_15_30_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.heliyon.2023.e23507"}],"container-title":["Canadian Journal of Gastroenterology and Hepatology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/pdf\/10.1155\/cjgh\/5689742","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/full-xml\/10.1155\/cjgh\/5689742","content-type":"application\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/pdf\/10.1155\/cjgh\/5689742","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,10]],"date-time":"2026-08-10T07:25:31Z","timestamp":1786346731000},"score":1,"resource":{"primary":{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/10.1155\/cjgh\/5689742"}},"subtitle":[],"editor":[{"given":"Takaya","family":"Shimura","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"editor"}]}],"short-title":[],"issued":{"date-parts":[[2026,1]]},"references-count":30,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2026,1]]}},"alternative-id":["10.1155\/cjgh\/5689742"],"URL":"https:\/\/doi.org\/10.1155\/cjgh\/5689742","archive":["Portico"],"relation":{},"ISSN":["2291-2789","2291-2797"],"issn-type":[{"value":"2291-2789","type":"print"},{"value":"2291-2797","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,1]]},"assertion":[{"value":"2026-04-16","order":0,"name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2026-07-16","order":2,"name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}},{"value":"2026-08-10","order":3,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}],"article-number":"5689742"}}